17-Dimethylaminoethylamino-17-demethoxygeldanamycin | |
---|---|
[(3R,5S,6R,7S,8E,10S,11S,12Z,14E)-21-(2-dimethylaminoethylamino)-6-hydroxy-5,11-dimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-17-azabicyclo[16.3.1]docosa-1(21),8,12,14,18-pentaen-10-yl] carbamate |
|
Other names
17-DMAG; Alvespimycin |
|
Identifiers | |
CAS number | 467214-20-6 |
PubChem | 5288674 |
ChemSpider | 16744073 |
ChEMBL | CHEMBL383824 |
Jmol-3D images | Image 1 Image 2 |
|
|
|
|
Properties | |
Molecular formula | C32H48N4O8 |
Molar mass | 616.75 g mol−1 |
(verify) (what is: / ?) Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) |
|
Infobox references |
17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) is a chemical compound which is a semi-synthetic derivative of the antibiotic geldanamycin.[1][2] It is being studied for the possibility of treating cancer.[3]